Physician profile
Michael Taunton
NPI 1992784854
$3,530,758.40
in general payments reported to CMS, 2019-2025
9 companies · $1.6M in 2025
The $1.6M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $456K · 2020: $488K · 2021: $507K · 2022: $177K · 2023: $148K · 2024: $159K · 2025: $1.6M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.5M · Consulting Fee: $360K · Travel and Lodging: $67K · Food and Beverage: $2,806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,473,462.96 |
| Consulting Fee | $359,900.00 |
| Travel and Lodging | $66,682.20 |
| Food and Beverage | $2,805.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, Lp | $3,472,652.44 | 2019-2025 | Djo Surgical |
| Djo, LLC | $45,629.17 | 2019-2023 | Procare |
| Insight Medical Systems, INC. | $11,516.91 | 2023-2024 | Arvis |
| Medical Device Business Services, INC. | $675.00 | 2020 | |
| Depuy Synthes Sales INC. | $105.95 | 2019 | |
| Onkos Surgical, INC. | $105.11 | 2021 | |
| Orthalign INC | $48.34 | 2022 | |
| Globus Medical, INC. | $25.48 | 2025 | Actify 3d |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Taunton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.